CURIS INC
S-4/A, EX-27.3A, 2000-05-31
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CURIS INC, S-4/A, EX-27.3, 2000-05-31
Next: TSET INC, 10QSB, 2000-05-31



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ONTOGENY,
INC. AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               MAR-31-2000             MAR-31-1999
<CASH>                                      21,403,085                       0
<SECURITIES>                                18,228,604                       0
<RECEIVABLES>                                   65,025                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                               526,443                       0
<PP&E>                                       7,840,598                       0
<DEPRECIATION>                             (2,935,657)                       0
<TOTAL-ASSETS>                              45,581,827                       0
<CURRENT-LIABILITIES>                        6,244,318                       0
<BONDS>                                         50,000                       0
                       62,444,153                       0
                                  8,738,123                       0
<COMMON>                                        37,755                       0
<OTHER-SE>                                (34,601,800)                       0
<TOTAL-LIABILITY-AND-EQUITY>                45,581,827                       0
<SALES>                                              0                       0
<TOTAL-REVENUES>                               750,000               1,250,000
<CGS>                                                0                       0
<TOTAL-COSTS>                                9,406,827               4,579,225
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                           (164,811)               (297,280)
<INCOME-PRETAX>                            (8,244,149)             (2,986,413)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (8,244,149)             (2,986,413)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (8,244,149)             (2,986,413)
<EPS-BASIC>                                     (2.65)                  (1.23)
<EPS-DILUTED>                                   (2.65)                  (1.23)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission